Healthcare Magazine September 2014 | Page 54

Medtech Ethiopia

For the past 16 years , Ethiopia ’ s pharmaceutical industry has developed alongside Medtech Ethiopia and EPHARM , ensuring that this latest acquisition will optimise the international influence of both

Internal Operations

Medtech Ethiopia has signaled its intentions in recent years through various acquisitions and diversifications , and is well on its way to benefiting from its most significant investment to date .

The Ethiopian pharmaceutical company ’ s recent acquisition of EPHARM ( Ethiopian Pharmaceuticals Manufacturing Factory ) signals a full circle in the business ’ s 16-year development , which initially saw it operate as a distributor for the latter to fill the demand gap in Ethiopia .
Founder and Chief Executive Officer ( CEO ), Dr . Mohammed Nuri , was the innovator who noticed the concerning trend and has not looked back since deciding to form the country ’ s first pharmaceutical supplier .
“ I am a doctor by background , and was really frustrated by the shortage of availability of pharmaceutical products in the country ,” he said . “ This is what pushed me to go into this field and with the Ethiopian market untested at the time , we grew exponentially .
“ From five staff members in a three-room office , with capital of $ 50,000 , we have now registered more than 300 pharmaceutical products from more than 20 global suppliers . We are ISO certified and one of the top pharmaceutical companies in Ethiopia .”
EPHARM acquisition EPHARM has been a government-owned organisation for the past 50 years , establishing an
54 September 2014